In the first half of 2026 too, we continued to strongly execute our strategy with continuous growth for the Galenica Group. We have once again achieved strong sales growth of 7.1% to CHF 2.136 billion ...
Second quarter Operating EBITDA* of negative $21.0 million (net loss of $76.0 million), including a non-cash inventory impairment of $29.0 million, compared to negative $20.9 million (net loss of $86.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results